Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
1
25%
Ph not_applicable
2
50%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(1)
Other(3)

Detailed Status

unknown3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

unknown375%
withdrawn125%

Recent Activity

0 active trials
Showing 4 of 4
unknownphase_2

DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma

NCT02487017
withdrawnnot_applicable

SBRT + TACE for Primary Hepatocellular Carcinoma

NCT00746655
unknownnot_applicable

A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

NCT00563095
unknownphase_4

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

NCT01102335

Clinical Trials (4)

Showing 4 of 4 trials
NCT02487017Phase 2

DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma

Unknown
NCT00746655Not Applicable

SBRT + TACE for Primary Hepatocellular Carcinoma

Withdrawn
NCT00563095Not Applicable

A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

Unknown
NCT01102335Phase 4

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4